Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$2.16B |
| 2 |
Hershey
HSY
|
+$663M |
| 3 |
Lockheed Martin
LMT
|
+$622M |
| 4 |
Altria Group
MO
|
+$525M |
| 5 |
Pfizer
PFE
|
+$499M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$2.76B |
| 2 |
Merck
MRK
|
+$2.35B |
| 3 |
Automatic Data Processing
ADP
|
+$1.57B |
| 4 |
Blackstone
BX
|
+$1.38B |
| 5 |
Illinois Tool Works
ITW
|
+$1.13B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.85% |
| 2 | Financials | 12.71% |
| 3 | Healthcare | 11.72% |
| 4 | Consumer Discretionary | 10.09% |
| 5 | Industrials | 9.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2176
Washington Trust Bancorp
WASH
$755M
| $6.83M | ﹤0.01% |
254,172
+18,586
| +8% | +$510K |
|
2177
Yext
YEXT
$569M
| $6.83M | ﹤0.01% |
1,132,875
+24,452
| +2% | +$145K |
|
2178
Mirum Pharmaceuticals
MIRM
$6.38B
| $6.82M | ﹤0.01% |
271,654
+4,973
| +2% | +$137K |
|
2179
Nu Holdings
NU
$69.8B
| $6.77M | ﹤0.01% |
567,634
+148,676
| +35% | +$1.52M |
|
|
BASE
2180
DELISTED
Couchbase
BASE
| $6.77M | ﹤0.01% |
257,306
+6,834
| +3% | +$178K |
|
2181
Repay Holdings
RPAY
$343M
| $6.73M | ﹤0.01% |
611,841
+6,161
| +1% | +$54.5K |
|
|
AMK
2182
DELISTED
AssetMark Financial Holdings, Inc.
AMK
| $6.72M | ﹤0.01% |
189,894
+18,405
| +11% | +$602K |
|
2183
1-800-Flowers.com
FLWS
$269M
| $6.71M | ﹤0.01% |
619,467
+36,267
| +6% | +$372K |
|
2184
ZipRecruiter
ZIP
$342M
| $6.71M | ﹤0.01% |
583,875
+7,657
| +1% | +$103K |
|
2185
Seaboard Corp
SEB
$4.21B
| $6.7M | ﹤0.01% |
2,078
+41
| +2% | +$141K |
|
2186
Life Time Group Holdings
LTH
$9.87B
| $6.69M | ﹤0.01% |
431,260
+7,386
| +2% | +$103K |
|
2187
Revolve Group
RVLV
$1.86B
| $6.69M | ﹤0.01% |
315,949
+492
| +0.2% | +$8.63K |
|
2188
First Advantage
FA
$3.5B
| $6.68M | ﹤0.01% |
412,083
+5,442
| +1% | +$88.8K |
|
2189
CryoPort
CYRX
$781M
| $6.59M | ﹤0.01% |
372,149
+6,118
| +2% | +$96.9K |
|
2190
Archer Aviation
ACHR
$3.69B
| $6.49M | ﹤0.01% |
1,404,648
+18,242
| +1% | +$91.6K |
|
|
VERV
2191
DELISTED
Verve Therapeutics
VERV
| $6.47M | ﹤0.01% |
487,007
+117,337
| +32% | +$1.56M |
|
|
BELFB
2192
Bel Fuse Inc Class B
BELFB
$3.91B
| $6.45M | ﹤0.01% |
107,023
+7,307
| +7% | +$453K |
|
2193
Arcturus Therapeutics
ARCT
$171M
| $6.44M | ﹤0.01% |
190,766
+4,456
| +2% | +$158K |
|
2194
Bristow Group
VTOL
$1.35B
| $6.43M | ﹤0.01% |
236,552
+36,363
| +18% | +$969K |
|
|
FLNA
2195
Filana Therapeutics
FLNA
$49.8M
| $6.42M | ﹤0.01% |
316,391
+7,555
| +2% | +$174K |
|
2196
Pliant Therapeutics
PLRX
$64.4M
| $6.41M | ﹤0.01% |
430,286
+6,090
| +1% | +$100K |
|
2197
Fulgent Genetics
FLGT
$500M
| $6.4M | ﹤0.01% |
294,940
+27,627
| +10% | +$686K |
|
2198
PureCycle Technologies
PCT
$1.41B
| $6.38M | ﹤0.01% |
1,025,119
+3,574
| +0.3% | +$16.6K |
|
2199
Editas Medicine
EDIT
$407M
| $6.35M | ﹤0.01% |
856,095
+172,079
| +25% | +$1.43M |
|
|
LOGC
2200
DELISTED
ContextLogic
LOGC
| $6.35M | ﹤0.01% |
1,116,120
+250,348
| +29% | +$1.38M |
|
Similar funds
Charles Schwab's Q1 2024 Portfolio in Review
As of Q1 2024, Charles Schwab held 3,573 positions worth $433B, up 10% from $394B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Trading was light in Q1 2024: portfolio turnover was 3.8%. Charles Schwab opened 35 new positions and exited 102, leaving the 3,573-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q1 2024 buy was Schwab Fundamental US Large Company Index ETF: 3,608,604 shares worth $81.1M.
- Charles Schwab added most to Bristol-Myers Squibb in Q1 2024, an estimated $2.16B increase.
- Charles Schwab's biggest Q1 2024 reduction was Broadcom, cutting an estimated $2.76B.
- Charles Schwab fully exited Splunk Inc in Q1 2024, selling an estimated $104M.
- Charles Schwab's ten largest holdings make up 20% of its $433B portfolio in Q1 2024.
- Charles Schwab opened 35 new positions and closed 102 in Q1 2024.
- Charles Schwab's portfolio value rose 10% quarter-over-quarter to $433B.
Based on Charles Schwab's 13F filing for Q1 2024, filed 9 May 2024.